Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 124

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 1B
Chunk 124
---
 3,746

    139,097

    Total revenue

    3,746

    140,141

    Operating expenses:

    Cost of product revenue

    —

    15,624

    Research and development

    26,405

    30,928

    Selling, general and administrative

    14,458

    20,920

    Total operating expenses

    40,863

    67,472

    (Loss) income from operations

    (37,117
    )

    72,669

    Other expense (income):

    Amortization of debt issuance costs and discount

    1,726

    2,994

    Interest income

    (4,291
    )

    (3,954
    )

    Interest expense

    828

    3,130

    Other income

    (235
    )

    —

    Warrant liabilities fair value adjustment

    (13,812
    )

    3,166

    Derivative liability fair value adjustment

    (196
    )

    154

    Total other (income) expense

    (15,980
    )

    5,490

    (Loss) income before taxes

    (21,137
    )

    67,179

    Income tax (expense)

    (151
    )

    (138
    )

    Net (loss) income
     
    $
    (21,288
    )
     
    $
    67,041

    Net (loss) income per share attributable to common stockholders – basic

    Net (loss) income per share – basic
     
    $
    (0.44
    )
     
    $
    1.40

    Net (loss) income per share attributable to common stockholders – diluted

    Net (loss) income per share – diluted
     
    $
    (0.44
    )
     
    $
    1.39

    Weighted average common shares outstanding – basic and diluted

    Basic

    48,513,073

    47,852,833

    Diluted

    48,513,073

    48,390,582

The accompanying notes are an integral part of the financial statements.

60

SCYNEXIS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQU